Lea Ann Browning-McNee Director of Communications & Stakeholder Engagement at the Reagan-Udall Foundation for the FDA
-
June 29, 2021
Helping Patients Access Investigational Treatments
With:For some advanced cancer patients, the best course of action may lie beyond standard treatment options. Some of these patients can enroll in clinical trials that investigate promising new treatments. But others may find their best option is to apply for individual “expanded access” to an investigational treatment. Here, our Curious Dr. George asks two leaders from the Reagan-Udall Foundation for the Food and… Read more »